Bill Sibold, Madrigal Pharmaceuticals CEO, joins 'Fast Money' to discuss Q2 earnings results, the weight loss space and their ...

Madrigal Pharmaceuticals (MDGL) stock gains as the company's Q2 2025 results exceed expectations with a 15-fold surge in ...

Madrigal Pharmaceuticals Inc. MDGL) on Tuesday reported a loss of $42.3 million in its second quarter.

Second-quarter 2025 Rezdiffra™ (resmetirom) net sales of $212.8 millionAs of June 30, 2025, more than 23,000 patients on Rezdiffra Received new U.S. Rezdiffra patent providing protection to Feb. 4, ...

Las Vegas(KLAS)-TV Personality, Peter Madrigal, has launched ‘Reality Network’ providing a one stop shop for all things ...

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...

Learn insights from Madrigal Pharmaceuticals' Q2 2025 earnings: Rezdiffra's growth, new patent till 2045, global expansion, and pipeline advances.

Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.

Anthony Madrigal with the Twenty-Nine Palms Band of Mission Indians distributes free backpacks with school supplies for ...

Two iconic 20th Century Studios franchises, Alien and Planet of the Apes, have joined the must-watch sci-fi movies on HBO Max ...

Roivant Sciences has received a total of 2 ratings from analysts, with the consensus rating as Buy. With an average one-year ...

New York Mets (63-53, second in the NL East) vs. Milwaukee Brewers (71-44, first in the NL Central) Milwaukee; Saturday, 7:10 p.m. EDT PITCHING PROBABLES: Mets: TBD; Brewers: Tobias Myers (1-1, 4.30 ...